Trials / Completed
CompletedNCT03244826
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 404 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.
Detailed description
Hematopoietic Cell Transplantation (HCT) - also known as bone marrow transplant - is only available at select centers in the United States which can collect and store stem cells, as well as care for patients before their new immune system cells take hold. For this reason, many patients who undergo HCT live at great distances from their HCT center. Also, after hospital discharge, the first 180 days post-HCT are very important, as patients must be managed closely with frequent follow-up visits. A potential way to make life easier for HCT patients is to allow some of the post-transplant care to be provided by local oncologists who practice closer to where patients live. This could reduce the burden on patients and their caregivers; however, it is not known if a shared care model would ultimately benefit them. The investigators want to assess the effectiveness of a Shared Care program which allows patients to receive half of their post-HCT care at the HCT center, and the other half with their local oncologist
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Shared Care | Shared Care involves four specific strategies to allow patients to have a portion of their care locally after HCT, where clinic and laboratory visits are equally shared between the local oncologist and primary HCT team |
| OTHER | Standard Care | The usual care provided by the transplant center at DFCI. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2022-08-22
- Completion
- 2022-08-22
- First posted
- 2017-08-10
- Last updated
- 2024-08-16
- Results posted
- 2024-08-16
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03244826. Inclusion in this directory is not an endorsement.